MSB 3.33% $1.40 mesoblast limited

Hostile takeover

  1. 1,763 Posts.
    lightbulb Created with Sketch. 195
    I think we all have to look at the possibility that a hostile takeover has to be on the cards for a number of reason.
    Future growth in stem cell therapy
    near approval of a number of stem cell products
    Hugh turnover in the shares over the past week.
    greed of fund manages to lock in big profits before the end of year
    low And

    even at the close of price in the US on Friday a full takeover price 15.45 USD = 4.84 AUD
    4.84 * 537.27m shares = @ 2.600b and in USD that is only 1.66b USD a drop in the ocean for any large global pharmaceutical company. Not even the value of one qtr of a year in r&d for some company's

    even if you take a 50% premium on the share price on Friday night that still is on
    15.45 + 50% = 23.17 USD or 7.25aud that again is a total takeover of 3.895b Aud or only 2.487b usd

    best case the high on friday night of 20.57 usd plus 50% premium = 30.85 usd or 9.66 aud
    that would be a 5.190b and or 3.314b USD

    a fund manager looking at these types of profits off setting the Mark to Mark value of there current share portfolio would have to ready sit up and have a look at this.

    any comments
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.40
Change
0.045(3.33%)
Mkt cap ! $1.592B
Open High Low Value Volume
$1.35 $1.42 $1.33 $3.802M 2.753M

Buyers (Bids)

No. Vol. Price($)
2 23940 $1.39
 

Sellers (Offers)

Price($) Vol. No.
$1.40 22571 2
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.